Drug
ifinatamab deruxtecan
1 HCP commentary report on clinical trials studying ifinatamab deruxtecan. Each report covers what clinicians said in public about one trial, with the source behind every view.
| Trial | Indication | Phase | Statements | HCP sources | Size | Updated | Preview |
|---|---|---|---|---|---|---|---|
| IDeate-Lung01Free NCT05280470 · Daiichi Sankyo | Small cell lung cancer | Phase 2 | 347 | 103 | Deep | Oct 21, 2026 | Preview |